GALIDESIVIR TRIAL | BCRX Message Board Posts

BioCryst Pharmaceuticals Inc.

  BCRX website

BCRX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  10142 of 10255  at  9/19/2019 3:14:15 PM  by

capecod3


GALIDESIVIR TRIAL

 Letter I resent to Biocryst. Can't wait to see if they respond
 

Good afternoon:

Re ClinicalTrials.gov Identifier: NCT03891420 study of Galidesivir treatment for yellow fever; has this study begun? It was listed on ClinicalTrials.gov six months ago.

Thank you for your prompt answer to my request of a month ago,

William Kwalwasser, PhD and shareholder



     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 5     Views: 139
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
10143 Re: GALIDESIVIR TRIAL mdaddy1234 0 9/19/2019 10:27:06 PM
10144 Re: GALIDESIVIR TRIAL lsquared 1 9/19/2019 11:06:45 PM


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...